MRS1754 inhibits proliferation and migration of bladder urothelial carcinoma by regulating mitogen-activated protein kinase pathway. [electronic resource]
Producer: 20200507Description: 11360-11368 p. digitalISSN:- 1097-4652
- Acetamides -- pharmacology
- Adenosine A2 Receptor Agonists -- pharmacology
- Adenosine A2 Receptor Antagonists -- pharmacology
- Aminopyridines -- pharmacology
- Animals
- Cell Line, Tumor
- Cell Movement -- drug effects
- Cell Proliferation -- drug effects
- G1 Phase Cell Cycle Checkpoints -- drug effects
- Humans
- JNK Mitogen-Activated Protein Kinases -- biosynthesis
- MAP Kinase Signaling System -- drug effects
- Mice
- Mice, Inbred BALB C
- Mice, Nude
- Purines -- pharmacology
- Receptor, Adenosine A2B -- drug effects
- Urinary Bladder Neoplasms -- drug therapy
- Urothelium -- pathology
- Xenograft Model Antitumor Assays
- p38 Mitogen-Activated Protein Kinases -- biosynthesis
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.